gut microbiota

Assessing the link between gut microbiome and neurodegenerative diseases to explore the potential of this critical field

Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, spoke about how the research in gut-brain axes could pave the way to new microbiome based therapies in neurodegenerative diseases.

The gut microbiota: a key player in obesity and weight management

Specific gut bacteria and/or metabolites could be responsible for the differential responses to weight management.

Maternal immune cells influence a newborn’s lung immunity through the microbiota

The findings of a new study suggest that a newborn’s lung immunity is influenced by the interplay between maternal γδ T cells, the gut microbiota and microbial-derived SCFAs.

Stress management during the COVID-19 pandemic: new trial finds probiotics to benefit the quality of sleep and mood

New study shows that specific probiotics significantly contribute to the modulation of mood and sleep quality during stressful periods.

Nanoparticles in food may affect gut microbiome

The results of the study showed that exposure to metal oxide nanoparticles led to changes in the microbial populations

Microbiota signature linked to chronic fatigue syndrome

The findings of two recent studies published in Cell Host & Microbe may help to develop new diagnostic tools and better animal models of ME/CFS.

TargEDys: the potential of LpWJL as a potent probiotic supporting juvenile growth

New study shows that these probiotic properties are strain-specific and involve NOD2 signaling. Components of its cell wall could be novel postbiotics.

Sacco System launches Microbiome, the complete suite to support companies worldwide

Marco Caspani: ‘With the launch of our new Microbial Therapeutic business-line we are directing our efforts and strong focus to the field of Biotherapeutics’.

How some gut microbes can promote obesity

The findings of a new study indicate that gut commensals may contribute to obesity through the overproduction of microbe-derived lipids.

Holobiome and Johnson & Johnson enter partnership to develop next-generation probiotics for infant and maternal health

Microbiome platform company Holobiome announces collaboration to support infant and maternal immune health.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top